Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
The study involves a six-month, double-blind protocol during which eighty patients, across
three sites around the country, will be randomly assigned to receive clozapine or olanzapine.
The specific aims of the study are to evaluate the relative effects of olanzapine and
clozapine on clinical outcomes and cognition in patients diagnosed with schizophrenia or
schizoaffective disorder who have demonstrated resistance to treatment in the past.
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center